Agenus | AGEN - EPS Earnings Per Share


Agenus reported $1.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.02 -0.650 -1.03 May/11
FY2025Q4 Dec/2025 -0.3 -0.270 -2.04 Mar/16
FY2025Q3 Sep/2025 1.94 -0.280 -3.08 Nov/10
FY2025Q2 Jun/2025 -1.0 -0.270 -2.52 Aug/11
Mar/2025 -1.03 -0.260 May/12




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Agenus USD 1.02 1.32 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Celldex Therapeutics USD -1.18 0.04 Mar/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.7 0.24 Mar/2026
Jiangsu Hengrui CNY 0.34 0.05 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Merck EUR 2.11 0.23 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Northwest Biotherapeutics USD -0.01 0.01 Sep/2025
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.52 0.01 Mar/2026